Financial News
Syros Pharmaceuticals (NQ: SYRS )
1.660
+0.040
(+2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Syros Pharmaceuticals
![](https://mms.businesswire.com/media/20230510005199/en/1788709/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230509005138/en/1786191/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230503005026/en/1778349/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230502005246/en/1779607/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230302005099/en/1727373/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230228005027/en/1719355/22/Syros_Logo.jpg)
Syros to Participate in Upcoming Investor Conferences in March
February 28, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230223005030/en/1719350/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230209005037/en/1707622/22/Syros_Logo.jpg)
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 09, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230126005350/en/1696704/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230109005156/en/1679677/22/Syros_Logo.jpg)
Syros Announces Clinical Updates and 2023 Strategic Priorities
January 09, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20221223005015/en/1671961/22/Syros_Logo.jpg)
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 23, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221212005205/en/1661396/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20221210005004/en/1660882/5/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20221205005039/en/1653245/5/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20221122005149/en/1644302/5/Syros_Logo.jpg)
Syros to Participate at Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221114005147/en/1634538/5/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20221107005013/en/1617863/5/Syros_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20221104005028/en/1623785/5/Syros_Logo.jpg)
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221103005107/en/1622582/5/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20221005005119/en/1592014/5/Syros_Logo.jpg)
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220916005472/en/1574559/5/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20220915005978/en/1573462/5/Syros_Logo.jpg)
Syros and Tyme Technologies Announce Stockholder Approval of Merger
September 15, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220913006229/en/1570701/5/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20220907005019/en/1558760/5/syros-logo-final_no-tag.jpg)
Syros to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220809005360/en/591952/5/syros-logo-final_no-tag.jpg)
![](https://mms.businesswire.com/media/20220804005150/en/591952/5/syros-logo-final_no-tag.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220803005673/en/591952/5/syros-logo-final_no-tag.jpg)
![](https://mms.businesswire.com/media/20220802005265/en/591952/5/syros-logo-final_no-tag.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.